Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02293018 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetic Study of MTC896 Gel in Subjects With Acne
A Phase 1 study, sponsored by Mimetica Pty Limited.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT02293018 is a Phase 1 study that has completed, run by Mimetica Pty Limited. The registered enrollment target is 32 participants.
The verdict
NCT02293018, a Phase 1 study, has completed, sponsored by Mimetica Pty Limited.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the pharmacokinetic properties of topically applied MTC896 Gel following application of 0.75% (w/w) MTC896 Gel once daily and twice daily and 1.5% (w/w) once daily over 4 weeks in the treatment of acne.
Interventions
- DRUG 0.75% (w/w) MTC896 Gel Once Daily
- DRUG 0.75% (w/w) MTC896 Gel Twice Daily
- DRUG 1.5% (w/w) MTC896 Gel Once Daily
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2014-08 |
| Est. Completion | 2015-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02293018
The ClinicalTrials.gov registry entry for NCT02293018 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mimetica Pty Limited, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which 0.75% (w/w) MTC896 Gel Once Daily is the first listed.
NCT02293018 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02293018 about?
NCT02293018 is a clinical study titled "Pharmacokinetic Study of MTC896 Gel in Subjects With Acne". The purpose of this study is to determine the pharmacokinetic properties of topically applied MTC896 Gel following application of 0.75% (w/w) MTC896 Gel once daily and twice daily and 1.5% (w/w) once daily over 4 weeks in the treatment of acne.
What is the current status of trial NCT02293018?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2014-08. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02293018?
The interventions under investigation include: 0.75% (w/w) MTC896 Gel Once Daily (DRUG), 0.75% (w/w) MTC896 Gel Twice Daily (DRUG), 1.5% (w/w) MTC896 Gel Once Daily (DRUG).
Who is sponsoring clinical trial NCT02293018?
This trial is sponsored by Mimetica Pty Limited, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.